Weight loss drugs added to WADA’s watchlist


GLP-1s could be added to the World Anti-Doping Agency’s prohibited list before the 2028 Olympics  Over the next two years, the World Anti-Doping Agency (WADA) is set to review whether use of glucagon-like peptide-1 medications gives athletes an unfair advantage, or if they violate the spirit of sport.   US-based publication, Pharmacy Times, noted that following WADA’s decision to monitor the medication class, “pharmacists should understand

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Research Roundup
Next People don’t change, do they?